Cargando…
COVID-19 treatment with lopinavir–ritonavir resulting in sick sinus syndrome: a case report
BACKGROUND: COVID-19 infection is the most serious global public health crisis of the century. With no approved treatments against it, investigational treatments are being used despite limited safety data. Besides being at higher risk of complications of COVID-19 infection, patients with underlying...
Autores principales: | Wang, Laureen Yi-Ting, Ng, Gavin Yeow Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337728/ https://www.ncbi.nlm.nih.gov/pubmed/33089048 http://dx.doi.org/10.1093/ehjcr/ytaa171 |
Ejemplares similares
-
Lopinavir/ritonavir: Sick sinus syndrome following off-label use: case report
Publicado: (2020) -
Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19
por: Mohsenian Naghani, Shaghayegh, et al.
Publicado: (2023) -
Propofol/lopinavir/ritonavir: Bradyarrythmia: case report
Publicado: (2020) -
Serotonin syndrome in two COVID-19 patients treated with lopinavir/ritonavir
por: Mas Serrano, Miguel, et al.
Publicado: (2020) -
Lopinavir/ritonavir monotherapy in clinical practice
por: Caso, A, et al.
Publicado: (2010)